CURE

NCCN Guidelines Adds New Test to Predict Melanoma Metastasis Risk

Now, a significant update to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology is ...
Yahoo

SkylineDx’s Merlin Test Recognized by NCCN for Melanoma

SkylineDx said its Merlin CP-GEP molecular test is uniquely recognized by the National Comprehensive Cancer Network (NCCN) for predictive use in select T1 and T2 melanoma patients. The test provides ...
Healio

Speaker discusses predictive power of Merlin test for low-, high-risk melanoma

Please provide your email address to receive an email when new articles are posted on . The Merlin test, a clinical-pathologic and gene expression profile, was able to successfully classify 37% of ...
Yahoo

SkylineDx’s Merlin Test Shows Predictive Accuracy in Early-Stage Melanoma

SkylineDx said its Merlin CP-GEP molecular test identifies a subset of T1a melanoma patients with sentinel lymph node (SLN) positivity above guideline thresholds. The National Comprehensive Cancer ...

Merlin CP-GEP™ Demonstrates Superior Predictive Accuracy for Sentinel Lymph Node Metastasis in Early-Stage Melanoma

SkylineDx today announced the publication of new data by Dr. Wesley Yu, et al ²., demonstrating that Merlin CP-GEP identifies a clinically meaningful High-Risk subset of T1a melanoma patients with a ...
Business Wire

Merlin Begins Industry First Flight Test Campaign of Certification-Ready Aircraft

BOSTON & MOJAVE, Calif.--(BUSINESS WIRE)--Merlin, the leading developer of safe, autonomous flight technology for fixed-wing aircraft, today announced it successfully began the flight test campaign of ...